StudyIntervention
A treatment, product or procedure being studied or used in the study, with its role (experimental, placebo, comparator, rescue) and how it is administered.
- Kind
- Concrete class
- Attributes
- 12, 5 required
- NCI code
- C207649
Official definition
Any agent, device, or procedure being tested or used as a reference or comparator in the conduct of a clinical trial.
In practice
In a protocol document: The study interventions table.
Attributes
12 attributes, 5 of them required by the USDM API schema.
| Attribute | Type | Card. | Definition |
|---|---|---|---|
| idrequired | string | cardinality 1 | The identifier of this object, unique within the file. |
| namerequired | string | cardinality 1 | The literal identifier (i.e., distinctive designation) of the study intervention. |
| label | string | cardinality 0..1 | The short descriptive designation for the study intervention. |
| description | string | cardinality 0..1 | A narrative representation of the study intervention. |
| rolerequired | Code | cardinality 1 | The intended use of the trial intervention within the context of the study design.USDM codelist C207417, 8 values |
| typerequired | Code | cardinality 1 | The kind of product or procedure studied in a trial.CDISC SDTM codelist C99078 (NCI EVS) |
| codes | Code | cardinality 0..* | A symbol or combination of symbols which is assigned to the study intervention.Values: Multiple Biomedical coding dictionaries such as WHODrug, ATC, UNII, etc. |
| minimumResponseDuration | Quantity | cardinality 0..1 | The value representing the minimum amount of time required to meet the criteria for response to study intervention. |
| notes | CommentAnnotation | cardinality 0..* | A brief written record relevant to the study intervention. |
| administrations | Administration | cardinality 0..* | A USDM relationship between the StudyIntervention and AgentAdministration classes which identifies the set of agent administrations associated with the study intervention. |
| extensionAttributes | ExtensionAttribute | cardinality 0..* | Extension attributes attached to this object, for information the standard does not define. Added by the API; not part of the logical model. |
| instanceTyperequired | string | cardinality 1 | The name of the class, carried by every object in a USDM JSON file. Added by the API; not part of the logical model. |
Allowed values
The coded attributes of StudyIntervention that use a codelist defined by USDM, with every value in it. A file carries the code; the term is its decode.
rolecodelist C207417, not extensible
| Code | Term | Definition |
|---|---|---|
| C207614 | Additional Required Treatment | A medicinal product that must be administered along with the experimental treatment (e.g., drug studies wherein opioid blockers are administered to prevent overdose). |
| C165822 | Background Treatment | Medicinal products that are administered to each clinical trial subject, regardless of randomization group, a) to treat the indication which is the object of the study, or b) required in the protocol as part of standard care for a condition that is not the indication under investigation, and is relevant for the clinical trial design. [After Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017] |
| C158128 | Challenge Agent | A non-investigational medicinal product (NIMP) given to trial subjects to produce a physiological response that is necessary before the pharmacological action of the investigational medicinal product can be assessed. [After Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017] |
| C18020 | Diagnostic | Any procedure or test to diagnose a disease or disorder. |
| C41161 | Experimental Intervention | The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224; https://grants.nih.gov/policy/clinical-trials/protocol-template.htm] See also test articles, devices, drug product, combination product, treatment, diagnosis. Contrast with investigational medicinal product. |
| C753 | Placebo | A pharmaceutical preparation that does not contain the investigational agent and is generally prepared to be physically indistinguishable from the preparation containing the investigational product. |
| C165835 | Rescue Medicine | Medicinal products identified in the protocol as those that may be administered to subjects when the efficacy of the investigational medicinal product (IMP) is not satisfactory, the effect of the IMP is too great and is likely to cause a hazard to the patient, or to manage an emergency situation. [After EU-CTR Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017] |
| C68609 | Active Comparator | A type of control, which has a demonstrated effect, administered as a comparator to subjects in a clinical trial. [From ICH E10] |
Smallest valid StudyIntervention
The attributes a JSON file must carry for a StudyIntervention, and the kind of value each takes. This is the shape, with types named in place of values. Everything else in the table above is optional.
{
"id": "StudyIntervention_1",
"name": string,
"role": Code,
"type": Code,
"instanceType": "StudyIntervention"
}
Where StudyIntervention is used
These classes hold or point to a StudyIntervention.
- Estimand.interventionIdsby id
- Procedure.studyInterventionIdby id
- StudyDesign.studyInterventionIdsby id
- StudyElement.studyInterventionIdsby id
- StudyVersion.studyInterventionsnested
Example
A StudyIntervention from the example study. Coded values are shortened to one line.
{
"id": "StudyIntervention_1",
"name": "EX-101",
"label": "EX-101 10 mg",
"description": "EX-101 10 mg tablet taken by mouth once daily for 12 weeks.",
"role": { "code": "C41161", "decode": "Experimental Intervention", … },
"type": { "code": "C1909", "decode": "Pharmacologic Substance", … },
"administrations": [
{
"id": "Administration_1",
"name": "EX-101 10 mg once daily",
"duration": {
"id": "Duration_1",
"text": "12 weeks",
"quantity": {
"id": "Quantity_1",
"value": 12,
"unit": { "standardCode": { "code": "C29844", "decode": "Week", … }, … },
"instanceType": "Quantity"
},
"durationWillVary": false,
"instanceType": "Duration"
},
"route": { "standardCode": { "code": "C38288", "decode": "Oral Route of Administration", … }, … },
"frequency": { "standardCode": { "code": "C25473", "decode": "Daily", … }, … },
"dose": {
"id": "Quantity_2",
"value": 10,
"unit": { "standardCode": { "code": "C28253", "decode": "Milligram", … }, … },
"instanceType": "Quantity"
},
"instanceType": "Administration"
}
],
"instanceType": "StudyIntervention"
}
Related classes
Other classes in interventions and products: